Results 111 to 120 of about 249,873 (317)
Strategic Planning Development Team Meeting Notes 12/16/2014
The opening of the meeting started with the meeting agenda. The budget presentation was scheduled for a date in January. Members of the Strategic Planning Development Team presented a series of questions to the attendees of the meeting to reflect on the ...
Strategic Planning Development Team
core
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio +8 more
wiley +1 more source
Cancer Research in 2030: A unique strategic planning process at a comprehensive cancer center. [PDF]
Bank EM, Small EJ, Ashworth A, Hiatt RA.
europepmc +1 more source
ABSTRACT Traumatic spinal cord injury (TSCI) caused by sharp‐force penetration is exceptionally rare, and the use of high‐dose methylprednisolone (MP) remains highly controversial, especially beyond the conventional 8‐h treatment window. This case report describes a 30‐year‐old male with acute incomplete TSCI following a knife stab wound to the right ...
Honghong Wang +5 more
wiley +1 more source
Strategic Planning Steering Committee, Agenda and Notes, October 26, 2011
Strategic Planning Steering Committee, Agenda and Notes, October 26 ...
Strategic Planning Steering Committee, UNO
core
Preclinical Safety Assessment of Antineoplastic Agents Based on Live Non-Pathogenic Enteroviruses
INTRODUCTION. Developing novel medicines based on non-pathogenic enterovirus strains exhibiting oncotropic and oncolytic properties represents an up-to-date and safe approach to complex cancer treatment and postoperative metastasis prevention.
K. V. Sivak +19 more
doaj +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Strategic Planning Steering Committee, Meeting Summary, September 28, 2005
Strategic Planning Steering Committee, Meeting Summary, September 28 ...
Strategic Planning Steering Committee, UNO
core
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
Strategic Planning Steering Committee, Meeting Summary, November 30, 2005
Strategic Planning Steering Committee, Meeting Summary, November 30 ...
Strategic Planning Steering Committee, UNO
core

